BridgeMD
New treatment option for Frozen Shoulder
Official title Vagus Nerve Stimulation Effect in Frozen Shoulder Treatment
ClinicalTrials.gov ID: NCT07368751
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if the addition of transcutaneous vagus nerve stimulation (tVNS) to exercise is effective in improving pain, shoulder function, shoulder range of motion, and psychological factors in adults with frozen shoulder. The main questions this study aims to answer are: Does adding tVNS to exercise reduce shoulder pain ?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 65
You may be able to join if
- Age between 40 and 65 years.
- Less than 50% range of motion compared with the contralateral shoulder in at least one movement (external rotation, abduction, flexion, or internal...
- More than 25% loss of range of motion in at least two movement planes compared with the unaffected shoulder.
- Increasing limitation of glenohumeral external and internal rotation during abduction from 45° to 90°.
- Shoulder pain lasting at least 3 months during activities of daily living.
You likely can't join if
- Passive joint range of motion within normal limits
- External rotation range of motion \<30°
- Radiographic evidence of glenohumeral arthritis
- Presence of inflammatory joint disease
- Previous treatment related to the current shoulder complaint (physiotherapy and rehabilitation, intra-articular injection, or surgery)
- Pain intensity \<3 according to the Numerical Pain Rating Scale (NPRS)
See the full eligibility criteria
- Age between 40 and 65 years.
- Less than 50% range of motion compared with the contralateral shoulder in at least one movement (external rotation, abduction, flexion, or internal rotation).
- More than 25% loss of range of motion in at least two movement planes compared with the unaffected shoulder.
- Increasing limitation of glenohumeral external and internal rotation during abduction from 45° to 90°.
- Shoulder pain lasting at least 3 months during activities of daily living.
- Passive joint range of motion within normal limits
- External rotation range of motion \<30°
- Radiographic evidence of glenohumeral arthritis
- Presence of inflammatory joint disease
- Previous treatment related to the current shoulder complaint (physiotherapy and rehabilitation, intra-articular injection, or surgery)
- Pain intensity \<3 according to the Numerical Pain Rating Scale (NPRS)
- Presence of neurological deficits, cardiac disease, neuropathic disorders, or pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.